# DAAN Biotherapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/daan-biotherapeutics

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.daanbiotpx.com/
- Total disclosed funding: $21M
- Latest round: Series A (Jan 25, 2024)
- Investors on record: 14

## About

Based in Seoul, South Korea, and founded in 2020, DAAN Biotherapeutics, Inc. operates as a biotechnology company dedicated to the development of treatments for cancer patients. As of January 2024, the company is led by its CEO, Byoung Chul Cho. In January 2024, DAAN Biotherapeutics, Inc. raised KRW 23 billion in series A funding from Atinum Investment, Stonebridge Ventures, DAYLI Partners, KB Investment, Solidus Investment, Heungkuk Securities, Shinhan Capital, FuturePlay, Solasta Ventures, Company K Partners, Timefolio Asset Management, and Paratus Investment.

DAAN Biotherapeutics, Inc., which engages in the development of cell therapy and antibody therapy for patients, specifically targets lung cancer by engineering T Cell Receptors (TCR) based on natural killer cells, specialized cells that have the ability to selectively and effectively target EGFR (Epidermal Growth Factor Receptor) mutations, a common characteristic of lung cancer. Additionally, DAAN Biotherapeutics, Inc. provides antibody therapeutics that target double or triple antibodies, inhibiting new targets discovered through single-cell transcriptome analysis of the tumor microenvironment. The company plans to use the January 2024 funding for research and development.

## Funding rounds

- Series A, Jan 25, 2024, $17M — KB Investment, Atinum Investment, Shinhan Capital, Timefolio Asset Management, Solidus Investment, Company K Partners, FuturePlay, Heungkuk Securities, Paratus Investment, DAYLI Partners, Solasta Ventures, Stonebridge Ventures
- Seed, Mar 28, 2022, $4.1M — Timefolio Asset Management, Company K Partners, Timefolio Capital, Paratus Investment, Solasta Ventures, Dong-Yu Technology Investment

## Investors

- Timefolio Asset Management — Seed, Series A
- Company K Partners (https://capitalatlas.ai/funds/company-k-partners) — Seed, Series A
- Timefolio Capital — Seed
- Paratus Investment (https://capitalatlas.ai/funds/paratus-investment) — Seed, Series A
- Solasta Ventures (https://capitalatlas.ai/funds/solasta-ventures) — Seed, Series A
- Dong-Yu Technology Investment (https://capitalatlas.ai/funds/dong-yu-technology-investment) — Seed
- KB Investment (https://capitalatlas.ai/funds/kb-investment) — Series A
- Atinum Investment (https://capitalatlas.ai/funds/atinum-investment) — Series A
- Shinhan Capital (https://capitalatlas.ai/funds/shinhan-capital) — Series A
- Solidus Investment (https://capitalatlas.ai/funds/solidus-investment) — Series A
- FuturePlay (https://capitalatlas.ai/funds/futureplay) — Series A
- Heungkuk Securities — Series A
- DAYLI Partners (https://capitalatlas.ai/funds/dayli-partners) — Series A
- Stonebridge Ventures — Series A